Table 1.
Baseline Characteristics of Study Participants (n = 13)
| Characteristic | Control Cyclea | NK3Ra Cyclea | P Value |
|---|---|---|---|
| Cycle day study commenced | 5.6 ± 0.2 | 5.0 ± 0.2 | 0.06 |
| LH, IU | 4.9 ± 0.5 | 4.8 ± 0.4 | 0.98 |
| FSH, IU | 5.1 ± 0.8 | 5.3 ± 0.9 | 0.82 |
| Estradiol, pmol/L | 160 ± 19 | 126 ± 13 | 0.07 |
| Follicle diameter, mm | 8.4 ± 0.4 | 8.1 ± 0.3 | 0.54 |
| Cycle-day pulsatility study | 11.1 ± 0.5 | 10.9 ± 0.2 | 0.75 |
| LH pulses/h at baseline | 0.69 ± 0.1 | N/A | N/A |
Data given as mean ± SEM.
Abbreviation: N/A, not applicable.
a
Control and NK3Ra-treated cycles were comparable by starting cycle day, reproductive hormone levels, and the size of the largest ovarian follicle.